IHS Chemical Week

World News and Views :: Projects

Wacker Builds Biologics

7:44 AM MDT | April 6, 2009

Wacker Chemie says it will develop its biologics operation at Jena, Germany as part of a strategy to expand the company’s fine chemicals business. The Jena facility specializes in using microbial systems, mainly E-coli, for the production of biologics. Wacker is investing about €15 million ($20 million) to expand the operation including a recently opened new process-development unit for pharmaceutical proteins. The company also will double the size of its Jena GMP production facility for biopharmaceuticals by year-end. Wacker has pulled out of contract...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa